Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M--Revenue $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M--EPS $--Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M--ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with XTL

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

XTL is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


XTL: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Quarterly/Annual Reports about XTL:

    News about XTL:

    Articles On GuruFocus.com
    Yacktman Fund Comments on Staples Feb 05 2016 
    Yacktman Fund Comments on Apollo Feb 05 2016 
    Yacktman Fund Comments on C.H. Robinson Feb 05 2016 
    Yacktman Fund Comments on PepsiCo Feb 05 2016 
    Yacktman Fund Comments on P&G Feb 05 2016 
    Yacktman Fund Comments on Microsoft Feb 05 2016 
    Auxier Asset Management Year-End 2015 Market Commentary Feb 05 2016 
    On Running a Concentrated Portfolio Feb 05 2016 
    Mario Gabelli Comments on Rolls-Royce Holding plc Feb 05 2016 
    Mario Gabelli Comments on Legg Mason Inc. Feb 05 2016 

    More From Other Websites
    XTL Biopharmaceuticals Joins Corporate Advisory Council of the Lupus Foundation of America Jan 27 2016
    S&P will end this year at 2,000, not 2,200, J.P. Morgan’s strategist says Jan 26 2016
    XTL Biopharmaceuticals Announces Encouraging Feedback from U.S. FDA on its Upcoming IND Filing for... Jan 25 2016
    What Lies Ahead for Telecom ETFs in 2016? Jan 19 2016
    XTL Biopharmaceuticals Advances Formulation of its hCDR1 Drug for Clinical Trials in the Treatment... Jan 13 2016
    XTL Biopharmaceuticals Submits Protocol to Yeda for Advanced Clinical Trial of hCDR1 in the... Jan 11 2016
    FEZ and EWJ Fall as Crude Oil Prices Plunge Further Dec 14 2015
    DuPont-Dow Megadeal Talk Stirs Materials ETFs Dec 09 2015
    Kite Pharma Leads IBB’s Mid-Caps on Its Zuma-1 Phase 1 Results Dec 09 2015
    Oil ETFs Dig A Hole But Could Syria Change That? Dec 08 2015
    Consumer Staples Didn’t Fall into Equity Market’s Downtrend Dec 08 2015
    SPY Ended Negative as Oil Sank to New Lows Dec 08 2015
    Alexion Tops IBB’s Large-Caps on Release of New Research Data Dec 08 2015
    U.S. benchmarks rattle the cage on important support Dec 08 2015
    Jet ETF Climbs, Dow In Red For 2015 As Oil Weighs Dec 07 2015
    Financial Sector Catches a Rate Hike Tailwind on December 4 Dec 07 2015
    Gung-Ho US Employment Scene Catapults SPY on December 4 Dec 07 2015
    How Are IBB’s American Depositary Receipts Performing? Dec 07 2015
    FEZ Rises by 1.2% on Strong Employment Data Dec 07 2015
    IHI’s Small Caps Outperformed the Market Dec 07 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK